Avalor Therapeutics, Inc. — Form D
Avalor Therapeutics, Inc. of Kenmore, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-05. The offering totals $800K, of which $335K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-05
- Form: D
- Accession: 0001994868-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $335K
- Remaining: $465K
- Minimum investment: $25K
- Investors: 6
- Date of first sale: 2023-08-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498811
Issuer
- Name: Avalor Therapeutics, Inc.
- CIK: 0001994868
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6700 NE 181st St., #82506, Kenmore, WA, 98028
- Phone: 8056376529
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Anthony E Ford | Director | Kenmore, WA |
| William E Martinez Zegarra | Director | Kenmore, WA |
| Kenneth E Wild | Director | Kenmore, WA |
| William E Martinez Zegarra | Executive Officer | Kenmore, WA |
More